Intervention Compliance - Tandem t:slim X2 User Manual

Chapter 33 – Basal-IQ Technology Clinical Study Overview

33.4 Intervention Compliance

Tables 2 and 3 below provide an outline of how often the t:slim X2 Insulin Pump with Basal-IQ Technology and CGM were used
during the study period respectively.
Table 2. Amount of t:slim X2 Insulin Pump with Basal-IQ Technology Use Over the 21-Day Period (N=102)
% of Time Using the Basal-IQ Technology
≥ 90%
80 to < 90%
70 to < 80%
60 to < 70%
50 to < 60%
< 50%
a. Denominator is the total possible time within 21-day post-randomization study period. Basal-IQ Technology use includes time in which Basal-IQ Technology was on and
available, on and suspended, and on and unavailable. The Basal-IQ Technology could be on and unavailable due to unavailable real-time CGM data or various pump statuses (e.g.,
total suspend time exceeds 120 minutes within a 150-minute period, user-override is active (manual resume), a standard bolus is in progress, no sensor session active, pumping
is not started, EGV is above 229 mg/dL, or too many missed readings).
300
Number of Participants
90
9
1
1
0
1
a
% of Study Population
88%
9%
< 1%
< 1%
0%
< 1%
Customer Technical Support: (877) 801-6901